Xeris Pharmaceuticals | XERS - Trade Debtors


Xeris Pharmaceuticals reported $51.05M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Celltrion KRW 1.51T 128.69B Sep/2025
Cspc Pharmaceutical CNY 8.85B 769.12M Jun/2025
Deva Holding AS TRY 3.03B 343.23M Sep/2023
Dianthus Therapeutics USD 52K 4.95M Dec/2025
Divis Laboratories Ltd INR 26.28B 1.16B Sep/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Kangmei Pharma CNY 3.15B 295.48M Sep/2025
Knight Therapeutics CAD 183M 7.46M Dec/2025
Laboratorios Farma EUR 143.38M 16.93M Dec/2023
Malin Corporation EUR 500K 300K Dec/2024
Medical Developments International AUD 7.48M 174K Dec/2025
Nektar Therapeutics USD 0 2.9M Sep/2024
Neuren Pharmaceuticals AUD 26.54M 5.83M Dec/2025
Organigram Holdings CAD 49.94M 14.92M Dec/2025
Ovoca Bio EUR 447K 113K Jun/2022
Pacira USD 124.07M 8.8M Dec/2025
Perrigo USD 612.8M 31.6M Dec/2025
Pharma Mar EUR 60.6M 18.83M Dec/2025
Qiagen NV USD 402.61M 9.05M Dec/2025
Sartorius EUR 344.7M 48.5M Sep/2025
Sino Biopharmaceutical CNY 8.45B 3.18B Jun/2025
Supernus Pharmaceuticals USD 187.8M 16.55M Dec/2025
Tilray USD 109.07M 2M Sep/2025
Zealand Pharma A/S 340M 94.1M Dec/2025
Zz Pientze Pharmaceu CNY 1.12B 222.78M Sep/2025